Alternatives to transvenous lead placement in a patient undergoing surgical tricuspid valve repair

Tricuspid regurgitation is a widely recognised phenomenon in patients with transvenous cardiac rhythm management (CRM) devices. If tricuspid valve repair or replacement is to be considered, what to do with the existing CRM system requires scrutiny with multidisciplinary input. We present a case of multifactorial tricuspid regurgitation in a 48‐year‐old female with giant cell myocarditis and a transvenous implantable cardioverter‐defibrillator (ICD). Key considerations in management and alternative CRM options are discussed.